Clinical trial
Community Screening Study of Diabetic Retinopathy in Tianjin in 2024
NCT06478407 is registered in ClinicalTrials.gov with Li Xiaorong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Community Screening Study of Diabetic Retinopathy in Tianjin in 2024
- Lead sponsor
- Li Xiaorong
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 28, 2024
- Completion date
- March 28, 2025
- Enrollment
- 18,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.